Acu-Flow Nebuliser Technology

Acu-Flow to advance the development of its nebuliser technology following a £1m grant from Innovate UK.

15:53 11 August 2022

A University of Glasgow spinout has recently secured a £1m grant from Innovate UK to advance its nebuliser technology. Acu-Flow uses innovative surface acoustic wave technique to deliver medicines into the patient's lungs. 

 

The Acu-Flow and its research partners at the University of Glasgow and the NIHR Devices for Dignity Med-tech Co-operative will be supported by the Innovate UK Biomedical Catalyst programme in the development of a fully-integrated nebuliser ready to take the large-scale manufacture. 

 

Dr Elijah Nazarzadeh, Acu-Flow Ltd’s CEO and a co-founder, said: “We’re delighted to have been awarded this significant grant from Innovate UK, which will allow us to accelerate our research and development over the next two years, helping us to bring our innovative and potentially life-changing technology to market.

 

“Respiratory diseases are the world’s leading causes of disability and death. Collectively, they add a huge burden to global health services. The COVID-19 pandemic has made us all aware of respiratory disease and the importance of new treatments to alleviate their effects.”

 

“While treatments for some of these diseases have advanced significantly in recent years, there are still significant challenges to overcome the efficient delivery of drugs directly to patients’ lungs. Our new technology will not only improve the amount of drug reaching the lung, but will enable new drug formulations, helping pharmaceutical companies to develop the next generation of life-changing treatments.